Israeli - Kiebrania - Ministry of Health

a. levy dental co. ltd, israel - epinephrine as bitartrate; lidocaine hydrochloride ( as monohydrate) - תמיסה להזרקה - epinephrine as bitartrate 12.5 mcg/ml; lidocaine hydrochloride ( as monohydrate) 20 mg/ml - lidocaine, combinations - lidocaine, combinations - for the production of local anaesthesia for dental procedures, by infiltration or nerve block injections.

Israeli - Kiebrania - Ministry of Health

abbott medical laboratories ltd - ascorbic acid 41.50 mg; biotin 70.10 mcg - liquid - other combinations of nutrients - specialized liquid nutrition for patients requiring protein, electrolyte and fluid restrictions. suplena is a high calorie low nitrogen, low electrolyte liquid food. in the dietary management of patients prone to uremia.

Israeli - Kiebrania - Ministry of Health

abbott medical laboratories ltd - artificial butterscotch flavor 146 mg / 100 g; artificial vanilla 1.9 g / 100 g - powder for suspension - fat/carbohydrates/proteins/minerals/vitamins, combinations - specialized elemental nutrition with glutamine for metabolically stressed patients with gastrointestinal complications.may be used as a sole source of nutrition or as a supplement to a prescribed diet.

Israeli - Kiebrania - Ministry of Health

abbott medical laboratories ltd - acid casein 3.9 g / 100 ml; ascorbic acid 51 mg / 100 ml - liquid - fat/carbohydrates/proteins/minerals/vitamins, combinations - specialized nutrition with fiber for patients with abnormal glucose tolerance. complete liquid nutrition.

Israeli - Kiebrania - Ministry of Health

לילית קוסמטיקה בעמ - צמצום קמטים וקמטוטים

Israeli - Kiebrania - Ministry of Health

a. levy dental co. ltd, israel - epinephrine as bitartrate; lidocaine hydrochloride ( as monohydrate) - תמיסה להזרקה - epinephrine as bitartrate 12.5 mcg / 1 ml; lidocaine hydrochloride ( as monohydrate) 20 mg / 1 ml - lidocaine, combinations

Israeli - Kiebrania - Ministry of Health

מדפורט בע"מ - רופא

Israeli - Kiebrania - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 1000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

Israeli - Kiebrania - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 2000 iu / 1 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

Israeli - Kiebrania - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 30000 iu / 0.75 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob